Key result
High peri-surgical opioid exposure was associated with increased odds of persistent opioid use at 30 days and 90 days post-discharge compared to low exposure.
Why the study?
A knowledge gap exists regarding the association between peri-surgical opioid exposure levels and post-discharge adverse outcomes to patients and healthcare settings.
Does high peri-surgical opioid exposure increase persistent opioid use and adverse outcomes in surgical patients?
Cohort
No
Does high peri-surgical opioid exposure increase persistent opioid use and adverse outcomes in surgical patients?
Higher peri-surgical opioid exposure is significantly associated with increased odds of persistent opioid use and greater healthcare resource utilization post-discharge.
Answers are grounded in this paper and cite their sources.
May support minimizing peri-surgical opioids; leaves open causal confirmation in randomized trials.
Background: Multiple studies have investigated the epidemic of persistent opioid use as a common postsurgical complication. However, there exists a knowledge gap in the association between the level of opioid exposure in the peri-surgical setting and post-discharge adverse outcomes to patients and healthcare settings. We analyzed the association between peri-surgical opioid exposure use and post-discharge outcomes, including persistent postsurgical opioid prescription, opioid-related symptoms (ORS), and healthcare resource utilization (HCRU). Methods: A retrospective cohort study included patients undergoing cesarean delivery, hysterectomy, spine surgery, total hip arthroplasty, or total knee arthroplasty in an academic healthcare system between January 2015 and June 2018. Peri-surgical opioid exposure was converted into morphine milligram equivalents (MME), then grouped into two categories: high (>median MME of each surgery cohort) or low (≤median MME of each surgery cohort) MME groups. The rates of persistent opioid use 30 and 90 days after discharge were compared using logistic regression. Secondary outcomes, including ORS and HCRU during the 180-day follow-up, were descriptively compared between the high and low MME groups. Results: The odds ratios (95% CI) of high vs. low MME for persistent opioid use after 30 and 90 days of discharge were 1.38 (1.24−1.54) and 1.41 (1.24−1.61), respectively. The proportion of patients with one or more ORS diagnoses was greater among the high-MME group than the low-MME group (27.2% vs. 21.2%, p < 0.01). High vs. low MME was positively associated with the rate of inpatient admission, emergency department admissions, and outpatient visits. Conclusions: Greater peri-surgical opioid exposure correlates with a statistically and clinically significant increase in post-discharge adverse opioid-related outcomes. The study findings warrant intensive monitoring for patients receiving greater peri-surgical opioid exposure.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2022) conducted a cohort in Post-surgical patients. High peri-surgical opioid exposure (>median MME) vs. Low peri-surgical opioid exposure (≤median MME) was evaluated on Persistent opioid use 30 days after discharge (OR 1.38, 95% CI 1.24-1.54). High peri-surgical opioid exposure was associated with increased odds of persistent opioid use at 30 days and 90 days post-discharge compared to low exposure.
Synapse has enriched 10 related papers. Consider them for comparative context: